Epizyme, Inc. (EPZM): Price and Financial Metrics
EPZM Price/Volume Stats
| Current price | $1.47 | 52-week high | $5.80 |
| Prev. close | $1.49 | 52-week low | $0.41 |
| Day low | $1.47 | Volume | 22,276,000 |
| Day high | $1.50 | Avg. volume | 3,225,203 |
| 50-day MA | $1.21 | Dividend yield | N/A |
| 200-day MA | $1.80 | Market Cap | 247.44M |
EPZM Stock Price Chart Interactive Chart >
Epizyme, Inc. (EPZM) Company Bio
Epizyme, Inc. discovers and develops epigenetic therapies for cancer patients. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Latest EPZM News From Around the Web
Below are the latest news stories about EPIZYME INC that investors may wish to consider to help them evaluate EPZM as an investment opportunity.
Aptinyx's (APTX) Mid-Stage Fibromyalgia Study Fails to Meet GoalAptinyx (APTX) reports disappointing data from a mid-stage study assessing NYX-2925 for the treatment of fibromyalgia. Stocks decline |
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/YEpizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates. |
The past five years for Epizyme (NASDAQ:EPZM) investors has not been profitableEpizyme, Inc. ( NASDAQ:EPZM ) shareholders will doubtless be very grateful to see the share price up 219% in the last... |
Epizyme (EPZM) Reports Q2 Loss, Tops Revenue EstimatesEpizyme (EPZM) delivered earnings and revenue surprises of 41.67% and 172.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock? |
Epizyme Reports Second Quarter 2022 Financial Results and Provides Business UpdateCAMBRIDGE, Mass., August 09, 2022--Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies for cancer patients against novel epigenetic targets, today reported second quarter 2022 financial results and provided a business update. |
EPZM Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -86.67% |
| 5-year | -84.33% |
| YTD | N/A |
| 2022 | 0.00% |
| 2021 | -76.98% |
| 2020 | -55.85% |
| 2019 | 299.35% |
| 2018 | -50.92% |
Continue Researching EPZM
Want to see what other sources are saying about Epizyme Inc's financials and stock price? Try the links below:Epizyme Inc (EPZM) Stock Price | Nasdaq
Epizyme Inc (EPZM) Stock Quote, History and News - Yahoo Finance
Epizyme Inc (EPZM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...